FDA.reportPublic FDA data

CYTARABINE

Substance profile for UNII 04079A1RDZ, enriched with FDA NDC listings, DailyMed labels, legacy aliases, and open chemistry identifiers.

Chemical structure for CYTARABINE
Structure render from PubChem CID 6253

Substance Identity#

UNII
04079A1RDZ
Preferred term
CYTARABINE
Registry number
147-94-4
EC number
205-705-9
Ingredient type
INGREDIENT SUBSTANCE
Molecular formula
C9H13N3O5
Chemical structure for CYTARABINE
Structure render from PubChem CID 6253

Chemical And Database Identifiers#

InChIKey
UHDGCWIWMRVCDJ-CCXZUQQUSA-N
SMILES
NC1=NC(=O)N(C=C1)[C@@H]2O[C@H](CO)[C@@H](O)[C@@H]2O
RxCUI
3041
PubChem
6253
NCIt
C408
INN ID
1709

Open Chemistry Sources#

Source, Identifier, Link table
SourceIdentifierLink
PubChem Compound6253pubchem.ncbi.nlm.nih.gov/compound/6253
PubChem InChIKey SearchUHDGCWIWMRVCDJ-CCXZUQQUSA-Npubchem.ncbi.nlm.nih.gov/#query=UHDGCWIWMRVCDJ-CCXZUQQUSA-N
RxNorm3041mor.nlm.nih.gov/RxNav/search?searchBy=RXCUI&searchTerm=3041
NCI ThesaurusC408ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C408
FDA Substance Registration System04079A1RDZprecision.fda.gov/uniisearch/srs/unii/04079A1RDZ
European Community number205-705-9commonchemistry.cas.org/results?q=205-705-9

DailyMed Socrata Ingredients#

Type, DailyMed label, SPL version table
TypeDailyMed labelSPL version
ACTIVE INGREDIENTCYTARABINE INJECTION, SOLUTION [HOSPIRA WORLDWIDE, INC.]12
ACTIVE MOIETYCYTARABINE INJECTION, SOLUTION [HOSPIRA WORLDWIDE, INC.]12
ACTIVE MOIETYCYTARABINE INJECTION, SOLUTION [HOSPIRA WORLDWIDE, INC.]12
ACTIVE INGREDIENTCYTARABINE INJECTION, SOLUTION [HOSPIRA WORLDWIDE, INC.]12
ACTIVE MOIETYDEPOCYT (CYTARABINE) INJECTION, LIPID COMPLEX [SIGMA-TAU PHARMACEUTICALS, INC.]8
ACTIVE INGREDIENTDEPOCYT (CYTARABINE) INJECTION, LIPID COMPLEX [SIGMA-TAU PHARMACEUTICALS, INC.]8
ACTIVE INGREDIENTCYTARABINE INJECTION, SOLUTION [HOSPIRA WORLDWIDE, INC.]5
ACTIVE MOIETYCYTARABINE INJECTION, SOLUTION [HOSPIRA WORLDWIDE, INC.]5
ACTIVE INGREDIENTCYTARABINE INJECTION [PFIZER LABORATORIES DIV PFIZER INC.]2
ACTIVE MOIETYCYTARABINE INJECTION [PFIZER LABORATORIES DIV PFIZER INC.]2
ACTIVE INGREDIENTCYTARABINE INJECTION [MYLAN INSTITUTIONAL LLC ]1
ACTIVE MOIETYCYTARABINE INJECTION [MYLAN INSTITUTIONAL LLC ]1
ACTIVE INGREDIENTCYTARABINE INJECTION [MYLAN INSTITUTIONAL LLC ]1
ACTIVE MOIETYCYTARABINE INJECTION [MYLAN INSTITUTIONAL LLC ]1
ACTIVE MOIETYCYTARABINE INJECTION [MYLAN INSTITUTIONAL LLC]1
ACTIVE INGREDIENTCYTARABINE INJECTION [MYLAN INSTITUTIONAL LLC]1
ACTIVE MOIETYCYTARABINE INJECTION [MYLAN INSTITUTIONAL LLC]1
ACTIVE INGREDIENTCYTARABINE INJECTION [MYLAN INSTITUTIONAL LLC]1
ACTIVE MOIETYCYTARABINE INJECTION [PFIZER LABORATORIES DIV PFIZER INC.]1
ACTIVE INGREDIENTCYTARABINE INJECTION [PFIZER LABORATORIES DIV PFIZER INC.]1
ACTIVE INGREDIENTCYTARABINE INJECTION [PFIZER LABORATORIES DIV PFIZER INC.]1
ACTIVE MOIETYCYTARABINE INJECTION [PFIZER LABORATORIES DIV PFIZER INC.]1
ACTIVE INGREDIENTCYTARABINE INJECTION [PFIZER LABORATORIES DIV PFIZER INC.]1
ACTIVE MOIETYCYTARABINE INJECTION [PFIZER LABORATORIES DIV PFIZER INC.]1
ACTIVE MOIETYCYTARABINE INJECTION, SOLUTION [APP PHARMACEUTICALS, LLC]1
ACTIVE INGREDIENTCYTARABINE INJECTION, SOLUTION [APP PHARMACEUTICALS, LLC]1
ACTIVE MOIETYCYTARABINE INJECTION, SOLUTION [HOSPIRA WORLDWIDE, INC.]1
ACTIVE INGREDIENTCYTARABINE INJECTION, SOLUTION [HOSPIRA WORLDWIDE, INC.]1